• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促甲状腺激素受体单克隆抗体表位中关键氨基酸残基的鉴定有助于深入了解其反向激动剂和拮抗剂特性。

Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into its inverse agonist and antagonist properties.

作者信息

Chen Chun-Rong, McLachlan Sandra M, Rapoport Basil

机构信息

Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.

出版信息

Endocrinology. 2008 Jul;149(7):3427-34. doi: 10.1210/en.2008-0207. Epub 2008 Apr 3.

DOI:10.1210/en.2008-0207
PMID:18388191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2453077/
Abstract

CS-17 is a murine monoclonal antibody to the human TSH receptor (TSHR) with both inverse agonist and antagonist properties. Thus, in the absence of ligand, CS-17 reduces constitutive TSHR cAMP generation and also competes for TSH binding to the receptor. The present data indicate that for both of these functions, the monovalent CS-17 Fab (50 kDa) behaves identically to the intact, divalent IgG molecule (150 kDa). The surprising observation that CS-17 competes for TSH binding to the human but not porcine TSHR enabled identification of a number of amino acids in its epitope. Replacement of only three human TSHR residues (Y195, Q235, and S243) with the homologous porcine TSHR residues totally abolishes CS-17 binding as detected by flow cytometry. TSH binding is unaffected. Of these residues, Y195 is most important, with Q235 and S243 contributing to CS-17 binding to a much lesser degree. The functional effects of CS-17 IgG and Fab on constitutive cAMP generation by porcinized human TSHR confirm the CS-17 binding data. The location of TSHR amino acid residues Y195, Q235, and S243 deduced from the crystal structure of the FSH receptor leucine-rich domain provides valuable insight into the CS-17 and TSH binding sites. Whereas hormone ligands bind primarily to the concave surface of the leucine-rich domains, a major portion of the CS-17 epitope lies on the opposite convex surface with a minor component in close proximity to known TSH binding residues.

摘要

CS-17是一种针对人促甲状腺激素受体(TSHR)的鼠单克隆抗体,具有反向激动剂和拮抗剂特性。因此,在没有配体的情况下,CS-17可减少组成型TSHR cAMP的生成,并且还能竞争TSH与受体的结合。目前的数据表明,对于这两种功能,单价CS-17 Fab(50 kDa)的行为与完整的二价IgG分子(150 kDa)相同。CS-17能与人而非猪的TSHR竞争TSH结合,这一惊人发现使得能够确定其表位中的一些氨基酸。用同源的猪TSHR残基仅替换人TSHR的三个残基(Y195、Q235和S243),通过流式细胞术检测发现完全消除了CS-17的结合。TSH结合不受影响。在这些残基中,Y195最为重要,Q235和S243对CS-17结合的贡献程度要小得多。CS-17 IgG和Fab对猪化人TSHR组成型cAMP生成的功能作用证实了CS-17的结合数据。从促卵泡激素受体富含亮氨酸结构域的晶体结构推导得出的TSHR氨基酸残基Y195、Q235和S243的位置,为CS-17和TSH结合位点提供了有价值的见解。激素配体主要结合在富含亮氨酸结构域的凹面上,而CS-17表位的大部分位于相对的凸面上,一小部分紧邻已知的TSH结合残基。

相似文献

1
Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into its inverse agonist and antagonist properties.促甲状腺激素受体单克隆抗体表位中关键氨基酸残基的鉴定有助于深入了解其反向激动剂和拮抗剂特性。
Endocrinology. 2008 Jul;149(7):3427-34. doi: 10.1210/en.2008-0207. Epub 2008 Apr 3.
2
A monoclonal antibody with thyrotropin (TSH) receptor inverse agonist and TSH antagonist activities binds to the receptor hinge region as well as to the leucine-rich domain.一种具有促甲状腺激素(TSH)受体反向激动剂和TSH拮抗剂活性的单克隆抗体,可与受体铰链区以及富含亮氨酸的结构域结合。
Endocrinology. 2009 Jul;150(7):3401-8. doi: 10.1210/en.2008-1800. Epub 2009 Mar 19.
3
TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.具有激动剂、拮抗剂和反向激动剂活性的促甲状腺激素受体单克隆抗体。
Methods Enzymol. 2010;485:393-420. doi: 10.1016/B978-0-12-381296-4.00022-1.
4
Structure of a Thyrotropin Receptor Monoclonal Antibody Variable Region Provides Insight into Potential Mechanisms for its Inverse Agonist Activity.促甲状腺激素受体单克隆抗体可变区结构提供了对其反向激动剂活性潜在机制的深入了解。
Thyroid. 2018 Jul;28(7):933-940. doi: 10.1089/thy.2018.0176. Epub 2018 Jun 29.
5
Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity.具有反向激动剂活性的单克隆抗体对促甲状腺素受体组成性活性的抑制作用。
Endocrinology. 2007 May;148(5):2375-82. doi: 10.1210/en.2006-1754. Epub 2007 Feb 1.
6
Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function.一种针对促甲状腺激素受体的人源单克隆自身抗体的特性:序列结构与功能
Thyroid. 2004 Aug;14(8):560-70. doi: 10.1089/1050725041692918.
7
Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.基于突变和对受体晶体结构此区域模糊性的重新评估,深入了解甲状腺刺激自身抗体与促甲状腺素受体 N 端的相互作用。
Thyroid. 2011 Sep;21(9):1013-20. doi: 10.1089/thy.2011.0147. Epub 2011 Aug 11.
8
Novel information on the epitope of an inverse agonist monoclonal antibody provides insight into the structure of the TSH receptor.新型抗独特型单克隆抗体表位信息为 TSH 受体结构提供了新视角。
PLoS One. 2012;7(2):e31973. doi: 10.1371/journal.pone.0031973. Epub 2012 Feb 16.
9
Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.促甲状腺激素(TSH)受体第三细胞质环不同区域的替换对组成性、TSH和TSH受体自身抗体刺激的磷酸肌醇及3',5'-环磷酸腺苷信号生成具有选择性作用。
Mol Endocrinol. 1993 Aug;7(8):1009-20. doi: 10.1210/mend.7.8.7901757.
10
Molecular interactions between the TSH receptor and a Thyroid-stimulating monoclonal autoantibody.促甲状腺激素受体与一种促甲状腺单克隆自身抗体之间的分子相互作用。
Thyroid. 2007 Aug;17(8):699-706. doi: 10.1089/thy.2007.0041.

引用本文的文献

1
Structure of a Thyrotropin Receptor Monoclonal Antibody Variable Region Provides Insight into Potential Mechanisms for its Inverse Agonist Activity.促甲状腺激素受体单克隆抗体可变区结构提供了对其反向激动剂活性潜在机制的深入了解。
Thyroid. 2018 Jul;28(7):933-940. doi: 10.1089/thy.2018.0176. Epub 2018 Jun 29.
2
Blocking type TSH receptor antibodies.阻断型促甲状腺激素受体抗体
Auto Immun Highlights. 2012 Mar 21;4(1):11-26. doi: 10.1007/s13317-012-0028-1. eCollection 2013 Apr.
3
Deleting the Redundant TSH Receptor C-Peptide Region Permits Generation of the Conformationally Intact Extracellular Domain by Insect Cells.删除冗余的促甲状腺激素受体C肽区域可使昆虫细胞产生构象完整的细胞外结构域。
Endocrinology. 2015 Jul;156(7):2732-8. doi: 10.1210/en.2015-1154. Epub 2015 Apr 10.
4
The hinge region of human thyroid-stimulating hormone (TSH) receptor operates as a tunable switch between hormone binding and receptor activation.人促甲状腺激素(TSH)受体的铰链区在激素结合和受体激活之间充当一个可调开关。
PLoS One. 2012;7(7):e40291. doi: 10.1371/journal.pone.0040291. Epub 2012 Jul 6.
5
The Synthesis and Evaluation of Dihydroquinazolin-4-ones and Quinazolin-4-ones as Thyroid Stimulating Hormone Receptor Agonists.二氢喹唑啉-4-酮和喹唑啉-4-酮作为促甲状腺激素受体激动剂的合成与评价
Medchemcomm. 2011 Oct;2(10):1016-1020. doi: 10.1039/C1MD00145K.
6
Novel information on the epitope of an inverse agonist monoclonal antibody provides insight into the structure of the TSH receptor.新型抗独特型单克隆抗体表位信息为 TSH 受体结构提供了新视角。
PLoS One. 2012;7(2):e31973. doi: 10.1371/journal.pone.0031973. Epub 2012 Feb 16.
7
Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.基于突变和对受体晶体结构此区域模糊性的重新评估,深入了解甲状腺刺激自身抗体与促甲状腺素受体 N 端的相互作用。
Thyroid. 2011 Sep;21(9):1013-20. doi: 10.1089/thy.2011.0147. Epub 2011 Aug 11.
8
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.一种人类促甲状腺激素受体的小分子反向激动剂。
Endocrinology. 2010 Jul;151(7):3454-9. doi: 10.1210/en.2010-0199. Epub 2010 Apr 28.
9
Thyrotropin (TSH) receptor residue E251 in the extracellular leucine-rich repeat domain is critical for linking TSH binding to receptor activation.甲状腺刺激素(TSH)受体胞外富含亮氨酸重复域中的 E251 残基对于连接 TSH 结合与受体激活至关重要。
Endocrinology. 2010 Apr;151(4):1940-7. doi: 10.1210/en.2009-1430. Epub 2010 Feb 24.
10
Human TSH receptor ligands as pharmacological probes with potential clinical application.作为具有潜在临床应用价值的药理学探针的人促甲状腺激素受体配体。
Expert Rev Endocrinol Metab. 2009 Nov 1;4(6):669. doi: 10.1586/eem.09.36.

本文引用的文献

1
Immune Deviation Away from Th1 in Interferon-γ Knockout Mice Does Not Enhance TSH Receptor Antibody Production after Naked DNA Vaccination.干扰素-γ基因敲除小鼠中远离Th1的免疫偏移在裸DNA疫苗接种后不会增强促甲状腺激素受体抗体的产生。
Endocrinology. 2002 Apr 1;143(4):1182-1189. doi: 10.1210/endo.143.4.8745.
2
The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction.促甲状腺激素受体铰链区并非仅仅是富含亮氨酸结构域的支架,而是有助于配体结合和信号转导。
Mol Endocrinol. 2008 May;22(5):1171-82. doi: 10.1210/me.2007-0407. Epub 2008 Jan 24.
3
An intracellular loop (IL2) residue confers different basal constitutive activities to the human lutropin receptor and human thyrotropin receptor through structural communication between IL2 and helix 6, via helix 3.一个细胞内环(IL2)残基通过IL2与螺旋6之间经由螺旋3的结构通讯,赋予人促黄体激素受体和人促甲状腺激素受体不同的基础组成活性。
Endocrinology. 2008 Apr;149(4):1705-17. doi: 10.1210/en.2007-1341. Epub 2007 Dec 27.
4
Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody.促甲状腺素受体与促甲状腺自身抗体复合物的晶体结构。
Thyroid. 2007 May;17(5):395-410. doi: 10.1089/thy.2007.0034.
5
Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity.具有反向激动剂活性的单克隆抗体对促甲状腺素受体组成性活性的抑制作用。
Endocrinology. 2007 May;148(5):2375-82. doi: 10.1210/en.2006-1754. Epub 2007 Feb 1.
6
Follitropin receptors contain cryptic ligand binding sites.促卵泡素受体含有隐蔽的配体结合位点。
Mol Cell Endocrinol. 2007 Jan 2;260-262:83-92. doi: 10.1016/j.mce.2006.06.012. Epub 2006 Oct 23.
7
Significance of ectodomain cysteine boxes 2 and 3 for the activation mechanism of the thyroid-stimulating hormone receptor.胞外域半胱氨酸盒2和3对促甲状腺激素受体激活机制的意义
J Biol Chem. 2006 Oct 20;281(42):31638-46. doi: 10.1074/jbc.M604770200. Epub 2006 Aug 9.
8
Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways.格雷夫斯病中针对促甲状腺激素受体的具有强大促甲状腺活性但阻断活性不同的单克隆致病性抗体可激活多种信号通路。
J Immunol. 2006 Apr 15;176(8):5084-92. doi: 10.4049/jimmunol.176.8.5084.
9
Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery.组成型受体活性与反向激动作用的最新进展及其在G蛋白偶联受体药物研发中的潜力。
Trends Pharmacol Sci. 2006 Feb;27(2):92-6. doi: 10.1016/j.tips.2005.12.007. Epub 2006 Jan 6.
10
Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.一种针对促甲状腺激素受体的单克隆抗体的特性,该抗体可作为一种强效的甲状腺刺激自身抗体拮抗剂。
Thyroid. 2005 Jul;15(7):672-82. doi: 10.1089/thy.2005.15.672.